D. Mul et al., Gonadotrophin releasing hormone agonist with or without recombinant human GH in children with early puberty, CLIN ENDOCR, 55(1), 2001, pp. 121-129
BACKGROUND Early onset of puberty is frequently observed in adopted childre
n. During treatment with a gonadotrophin releasing hormone agonist (GnRHa),
a decrease in height velocity (HV) precludes height gain.
OBJECTIVE AND DESIGN We studied the effect of the addition of GH to GnRHa t
reatment in a 3-year prospective randomized trial in 30 adopted children wi
th early puberty.
PATIENTS Mean age (SD) at start of treatment was 9.6 (0.9) years in girls a
nd predicted adult height (PAH) using a segmented bone age (BA) assessment
method was 148.0 (5.3) cm.
RESULTS HV decreased gradually in both groups with a higher HV in the group
with GH addition (group B). No significant difference between the rates of
bone maturation [change in bone age (ABA)/change in chronological age (ACA
)] of both treatment groups was observed. After 3 years of treatment, PAH i
ncrease was 5.7 (3.8) cm in group A (GnRHa alone) and 10.1 (3.8) cm in grou
p B (P < 0.01). IGF-I levels were higher in group B. HV decreased slowly in
both groups during treatment, unlike stabilization of IGF-I levels.
CONCLUSION We conclude that, after 3 years of treatment, the addition of GH
to GnRHa results in higher HV and a significant increase in PAH compared t
o GnRHa alone.